SOC Oncologia Medica e dei Tumori Immunocorrelati

Aviano 33081

1 studies enrolling now · 2 studies all time

What they study most

Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing, EGFR PACC, EGFR Uncommon Mutations, Follicular Lymphoma (FL), Marginal Zone Lymphoma, Metastatic Non-Small-Cell Lung Cancer, Non Hodgkin Lymphoma, Non-Small-Cell Lung Cancer

Studies at this site

• Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations — Recruiting now
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early